The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes

Hypertension in Pregnancy

Volumn 33, Issue 1, 2014, Pages 81-92

  Cohen, Allison L ^a,b   Wenger, Julia B ^c   James Todd, Tamarra ^d   Lamparello, Brooke M ^a   Halprin, Elizabeth ^a,b   Serdy, Shanti ^a,b   Fan, Shuling ^b   Horowitz, Gary L ^b   Lim, Kee Hak ^b   Rana, Sarosh ^b   Takoudes, Tamara C ^b   Wyckoff, Jennifer A ^e   Thadhani, Ravi ^c   Karumanchi, S Ananth ^b,f   Brown, Florence M ^a,b  

^a Joslin Clinic   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Angiogenesis; Diabetes; HbA1C; PlGF; Preeclampsia; SFlt1.

Indexed keywords

ANGIOGENIC FACTOR; HEMOGLOBIN A1C; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1; FLT1 PROTEIN, HUMAN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; PLACENTA PROTEIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PARITY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; THIRD TRIMESTER PREGNANCY; BLOOD; CASE CONTROL STUDY; COMPLICATION; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRE-ECLAMPSIA; PREGNANCY; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY PROTEINS; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84891499232     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2013.837175     Document Type: Article

References (34)

1. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592-4. (Pubitemid 40807500)
2. Sibai BM. Risk factors, pregnancy complications, and prevention of hypertensive disorders in women with pregravid diabetes mellitus. J Matern Fetal Med 2000;9: 62-5. (Pubitemid 30176215)
3. Garner PR, D'Alton ME, Dudley DK, et al. Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol 1990;163:505-8. (Pubitemid 20287618)
4. Howarth C, Gazis A, James D. Associations of Type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy. Diabet Med 2007;24:1229-34. (Pubitemid 47621803)
5. Hanson U, Persson B. Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden. Acta Obstet Gynecol Scand 1998;77:620-4. (Pubitemid 28416507)
6. Jensen DM, Damm P, Ovesen P, et al. Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study. Diabetes Care 2010;33:90-4.
7. Ekbom P, Damm P, Feldt-Rasmussen B, et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001;24:1739-44. (Pubitemid 33716475)
8. Combs CA, Rosenn B, Kitzmiller JL, et al. Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol 1993;82:802-7. (Pubitemid 23312190)
9. Price JH, Hadden DR, Archer DB, et al. Diabetic retinopathy in pregnancy. Br J Obstet Gynaecol 1984;91:11-17. (Pubitemid 14214325)
10. Hiilesmaa V, Suhonen L, Teramo K. Glycaemic control is associated with preeclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia 2000;43:1534-9. (Pubitemid 32734860)
11. Sibai BM, Caritis S, Hauth J, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000;182:364-9. (Pubitemid 30127349)
12. Cundy T, Slee F, Gamble G, Neale L. Hypertensive disorders of pregnancy in women with Type 1 and Type 2 diabetes. Diabet Med 2002;19:482-9. (Pubitemid 34639159)
13. Holmes VA, Young IS, Patterson CC, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care 2011;34:1683-8.
14. Temple RC, Aldridge V, Stanley K, et al. Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes. BJOG 2006;113: 1329-32. (Pubitemid 44581525)
15. Hsu CD, Hong SF, Nickless NA, Copel JA. Glycosylated hemoglobin in insulindependent diabetes mellitus related to preeclampsia. Am J Perinatol 1998;15: 199-202. (Pubitemid 28191196)
16. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83. (Pubitemid 38364626)
17. Powers RW, Jeyabalan A, Clifton RG, et al. Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One 2010;5:e13263.
18. Yu Y, Jenkins AJ, Nankervis AJ, et al. Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women. Diabetologia 2009;52:160-8.
19. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99:159-67.
20. Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;338:701-5.
21. Wothe D, Gaziano E, Sunderji S, et al. Measurement of sVEGF R1 and PlGF in serum: comparing prototype assays from Beckman Coulter, Inc. to R&D Systems microplate assays. Hypertens Pregnancy 2011;30:18-27.
22. Sunderji S, Gaziano E, Wothe D, et al. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study. Am J Obstet Gynecol 2010;202:40 e1-7.
23. Rana S, Powe CE, Salahuddin S, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012;125:911-19.
24. Oken E, Kleinman KP, Rich-Edwards J, GillmanMW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003;3:6.
25. Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care 2009;32: 2005-9.
26. Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;339:667-71.
27. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011;123:2856-69.
28. Kusanovic JP, Romero R, Chaiworapongsa T, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 2009;22:1021-38.
29. McElrath TF, Lim KH, Pare E, et al. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. Am J Obstet Gynecol 2012;207:407 e1-7.
30. Myatt L, Clifton RG, Roberts JM, et al. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol 2012;119:1234-42.
31. Signore C, Mills JL, Qian C, et al. Circulating angiogenic factors and placental abruption. Obstet Gynecol 2006;108:338-44. (Pubitemid 44305675)
32. Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995;172:642-8.
33. Lovestam-Adrian M, Agardh CD, Aberg A, Agardh E. Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in Type 1 diabetic patients. Diabet Med 1997;14:1059-65. (Pubitemid 28015391)
34. Ogge G, Romero R, Kusanovic JP, et al. Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice. J Matern Fetal Neonatal Med 2010;23:820-7.